151 related articles for article (PubMed ID: 36930254)
1. Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry.
Koelker M; Labban M; Frego N; Meyer CP; Salomon G; Lipsitz SR; Withington J; Moore CM; Tempany CM; Tuncali K; George A; Kibel AS; Trinh QD; Cole AP
World J Urol; 2023 May; 41(5):1309-1315. PubMed ID: 36930254
[TBL] [Abstract][Full Text] [Related]
2. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
[TBL] [Abstract][Full Text] [Related]
3. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Faure Walker NA; Norris JM; Shah TT; Yap T; Cathcart P; Moore CM; Ahmed HU; Emberton M; Minhas S
Urol Oncol; 2018 Feb; 36(2):67-76. PubMed ID: 29277585
[TBL] [Abstract][Full Text] [Related]
4. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.
Ward JF; Jones JS
BJU Int; 2012 Jun; 109(11):1648-54. PubMed ID: 22035200
[TBL] [Abstract][Full Text] [Related]
5. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
[TBL] [Abstract][Full Text] [Related]
7. Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy.
Stabile A; Sanchez-Salas R; Tourinho-Barbosa R; Macek P; Pellegrino F; Gandaglia G; Moschini M; Cathala N; Mombet A; Montorsi F; Briganti A; Cathelineau X
J Urol; 2021 Sep; 206(3):638-645. PubMed ID: 33890485
[TBL] [Abstract][Full Text] [Related]
8. A structured framework for optimizing high-intensity focused ultrasound ablative treatment in localized prostate cancer.
Castellani D; Branchi A; Claudini R; Gasparri L; Pierangeli T; Ravasi E; Dellabella M
Investig Clin Urol; 2019 Jul; 60(4):312-318. PubMed ID: 31294141
[TBL] [Abstract][Full Text] [Related]
9. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base.
Martin JM; Handorf EA; Kutikov A; Uzzo RG; Bekelman JE; Horwitz EM; Smaldone MC
Cancer; 2014 Jul; 120(14):2114-21. PubMed ID: 24737481
[TBL] [Abstract][Full Text] [Related]
10. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ
Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182
[TBL] [Abstract][Full Text] [Related]
11. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of men with high-risk localized prostate cancer in the United States.
Weiner AB; Matulewicz RS; Schaeffer EM; Liauw SL; Feinglass JM; Eggener SE
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):283-288. PubMed ID: 28631720
[TBL] [Abstract][Full Text] [Related]
13. Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.
Tourinho-Barbosa RR; Sanchez-Salas R; Claros OR; Collura-Merlier S; Bakavicius A; Carneiro A; Stabile A; Moschini M; Cathala N; Tobias-Machado M; Cathelineau X
J Urol; 2020 Feb; 203(2):320-330. PubMed ID: 31437121
[TBL] [Abstract][Full Text] [Related]
14. Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies.
Marinova M; Wilhelm-Buchstab T; Strunk H
Rofo; 2019 Mar; 191(3):216-227. PubMed ID: 30703824
[TBL] [Abstract][Full Text] [Related]
15. National Trends of Local Ablative Therapy Among Young Patients With Small Renal Masses in the United States.
Kiechle JE; Abouassaly R; Smaldone MC; Shah ND; Dong S; Cherullo EE; Nakamoto D; Zhu H; Cooney MM; Kim SP
Urology; 2015 Nov; 86(5):962-7. PubMed ID: 26341571
[TBL] [Abstract][Full Text] [Related]
16. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
17. Target ablation--image-guided therapy in prostate cancer.
Marien A; Gill I; Ukimura O; Betrouni N; Villers A
Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
[TBL] [Abstract][Full Text] [Related]
18. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer.
Rompré-Brodeur A; Marcq G; Tholomier C; Fugaru I; Loutochin O; Anidjar M; Bladou F
J Urol; 2021 Nov; 206(5):1177-1183. PubMed ID: 34251879
[TBL] [Abstract][Full Text] [Related]
19. Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
Dickinson L; Arya M; Afzal N; Cathcart P; Charman SC; Cornaby A; Hindley RG; Lewi H; McCartan N; Moore CM; Nathan S; Ogden C; Persad R; van der Meulen J; Weir S; Emberton M; Ahmed HU
Eur Urol; 2016 Oct; 70(4):668-674. PubMed ID: 26951947
[TBL] [Abstract][Full Text] [Related]
20. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
